Brain, Behavior, and Immunity publishes peer-reviewed studies dealing with behavioral, neural, endocrine, and immune system interactions in humans and animals.
✨Volume #126 of Brain, Behavior, and Immunity is now complete and available on @sciencedirect@BBI_Health@CarminePariante @ELSneuroscience #PNI
🔗Follow the link to see the full issue: https://t.co/SWV7GLod3S
🗨️ New BBI commentary from Professor Philip W.J. Burnet @OxPsychiatry @PNIRS @ELSneuroscience
Breaking barriers: How maternal bacteria influences foetal #neurodevelopment
🔗Read now: https://t.co/q5GH09B2Ix
✨Volume #126 of Brain, Behavior, and Immunity is now complete and available on @sciencedirect@BBI_Health@CarminePariante @ELSneuroscience #PNI
🔗Follow the link to see the full issue: https://t.co/SWV7GLod3S
New paper alert 🚨
Check out our latest in @BrainBehavImm:
LPS-induced systemic inflammation disrupts brain activity in a region- and vigilance-state specific manner.
https://t.co/Ohzbod1eOP
@lfp_unikarlova
Trending in #Psychiatry:
https://t.co/aohtdgUYml
1) Changes in vaping trends (@AddictionJrnl)
2) Noradrenergic signaling & Alzheimer’s disease pathology (@BrainBehavImm)
3) Catatonia in ICD-11
4) Eating disorders among Canadian & American boys and men
New #URochesterResearch suggests that calming the brain’s immune cells might prevent or lessen the damaging inflammation seen in Alzheimer’s disease
via @BrainBehavImm 👇 https://t.co/98SEjQgWh1
@URochester_SMD@UR_Med
https://t.co/OboaI0afnR
Enhancing norepinephrine signaling in brain #ImmuneCells may reduce #Inflammation and neuronal injury in Alzheimer's, highlighting a potential early, personalized #Treatment strategy. @brainbehavimm https://t.co/pnkwUl892w https://t.co/g4QwV7sbWv
Excited to share my PhD rotation work with the Majewska Lab on microglial noradrenergic signaling in Alzheimer's disease, now published on @BrainBehavImm 🧠
https://t.co/TxeBxAP5Uo
🟪 New in #BBI | CCL25 in the cerebrospinal fluid is negatively correlated with fatigue in chronic pain patients @PNIRS @ELSneuroscience @uppsalauni
Read more🔗https://t.co/Et5WuvuoSD
Check out our newest paper with the talented former Ph.D. Student @BD_Mckiver !
Astrocyte elevated gene-1 (AEG-1) in myeloid cells is a key driver for the development of chemotherapy-induced peripheral neuropathy.
https://t.co/005DrFbSF2
Always wanted to have a mug with my publication on it. Now I have 2!!!
Super excited and thank you to my incredible hubby @AHenryG@BrainBehavImm@BBI_Health ☺️
Another intriguing study published in @BrainBehavImm by @teenresilience, conducted at @UCLA_CousinsPNI, examines the negative effects of childhood adversities on immune adaptation and resilience, particularly in the context of recent chronic stress.
Link: https://t.co/wVpQVdSWZV
An interesting study published in @BrainBehavImm by @kierantayling states that higher levels of depressive symptoms were significantly associated with reduced SARS-CoV-2 spike-specific antibody levels following vaccination. Read more: https://t.co/a2NlI1IGlw
🦟 Scientists used single-cell sequencing technology to assess the immune response induced by three #ZIKV strains: Asian ancestral strain FSS13025/2010, FSS13025 strain with S139N mutation, and contemporary strain GZ01/2016.
@BrainBehavImm | https://t.co/IDzsNRLc0O
Immune system changes may predict #TreatmentResistance in #Schizophrenia, offering potential for earlier, targeted interventions. CD4/CD8 ratio and MAIT cell levels emerge as key biomarkers. @AstarHQ@brainbehavimm https://t.co/shv1sjPddc https://t.co/J8sw26ktlU
✨Volume #124 of Brain, Behavior, and Immunity is now complete and available on @sciencedirect
@ELSneuroscience @BBI_Health@CarminePariante#PNI
🔗Follow the link to see the full issue: https://t.co/fHeBN5bRu8